21 May 2019
Will the PARTNER 3 Low Risk trial change my practice?
Chairpersons:
T. Modine, S. Windecker
Session Reporter:
H. Mcconkey
Summary
Consult this session to learn more about the relevance of the PARTNER 3 Low Risk TAVI trial, how the results apply to specific patients and how they may impact your clinical practice.
Learning Objectives
- To learn about the relevance of the Low Risk TAVI trials
- To learn how the results of the low risk TAVI trials apply to specific patients
- To put the trial findings in context with intermediate and high-risk trial results